Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880058 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
A Phase 1 study, sponsored by Scarless Laboratories.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT03880058 is a Phase 1 study that has completed, run by Scarless Laboratories. The registered enrollment target is 22 participants.
The verdict
NCT03880058, a Phase 1 study, has completed, sponsored by Scarless Laboratories.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
Multicenter, double-blind study comparing SLI-F06 to vehicle formulation buffer for the improvement in scar appearance and wound strength in routine surgical excisions, as well as post-operative abdominoplasty scar appearance.
Interventions
- DRUG SLI-F06
- DRUG Formulation buffer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-03-03 |
| Est. Completion | 2021-05-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03880058
The ClinicalTrials.gov registry entry for NCT03880058 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scarless Laboratories, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SLI-F06 is the first listed.
NCT03880058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03880058 about?
NCT03880058 is a clinical study titled "Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance". Multicenter, double-blind study comparing SLI-F06 to vehicle formulation buffer for the improvement in scar appearance and wound strength in routine surgical excisions, as well as post-operative abdominoplasty scar appearance.
What is the current status of trial NCT03880058?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2019-03-03. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT03880058?
The interventions under investigation include: SLI-F06 (DRUG), Formulation buffer (DRUG).
Who is sponsoring clinical trial NCT03880058?
This trial is sponsored by Scarless Laboratories, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.